IMPACT OF SOCIAL DISTANCING MEASURES FOR

PREVENTING CORONAVIRUS DISEASE 2019

[COVID19]: A SYSTEMATIC REVIEW AND META-
ANALYSIS PROTOCOL
KELOMPOK 1
ULUL AZMI ( 19174035 )
MELDI ROSIMAH ( 19174052 )
RAHMIATI ( 19174036 )
MUAT MULIANA BANCIN ( 19174069 )
ULFATUL JAZILA ( 19174017 )

PRECEPTOR : . dr. Hadi Maulanza, M.K.M

Bagian SMF/ilmu Kesehatan Masyarakat fakultas
kedokteran universitas abulyatama
FILE JURNAL

TUGAS STASE IKM KEL 1 (2016).pdf

 Check
section/topic (page no)  Item  PRISMA checklist item  Page number
if done

TITLE 

Identify the report as a

Title (3) 1 systematic review, meta-analysis, √ 1
or both
 Check
section/topic (page no)  Item  PRISMA checklist item  Page number
if done
ABSTRAK

Provide a structured summary

including, as applicable:
background; objectives; data
sources; study eligibility criteria,
participants, and interventions;
Structured summary (4) 2 √ 2-3
study appraisal and synthesis
methods; results; limitations;
conclusions and implications of key
findings; systematic review
registration number.
 Check if
section/topic (page no)  Item  PRISMA checklist item  Page number
done
Introduction
Describe the rationale for the
Rational (5) 3 review in the context of what √ 3
is already known
 Check if
section/topic (page no)  Item  PRISMA checklist item  Page number
done
Introduction
Provide an explicit statement
of questions being addressed
with reference to participants,
Objectives (5) 4 √ 5
interventions, comparisons,
outcomes, and study design
(PICOS).
 Check if
section/topic (page no)  Item  PRISMA checklist item  Page number
done
Methods
Indicate if a review protocol
exists, if and where it can be
accessed (eg, web address), and,
Protocol and registration (6) 5 if available, provide registration √ 5
information including registration
number.
 Check if
section/topic (page no)  Item  PRISMA checklist item  Page number
done
Methods
Specify study characteristics (eg,
PICOS, length of follow-up) and
report characteristics (eg, years
Eligibility criteria (6) 6 √ 5-6
considered, language, publication
status) used as criteria for eligibility,
giving rationale.
 Check if
section/topic (page no)  Item  PRISMA checklist item  Page number
done
Methods
Describe all information sources
(eg, databases with dates of
coverage, contact with study
Information sources (7) 7 √ 6
authors to identify additional
studies) in the search and date
last searched.
 Check if
section/topic (page no)  Item  PRISMA checklist item  Page number
done
Methods
Present full electronic search
strategy for at least one
Search (7) 8 database, including any limits √ 7
used, such that it could be
repeated.
 Check if
section/topic (page no)  Item  PRISMA checklist item  Page number
done

Methods

State the process for selecting

studies (ie, screening, eligibility,
Study selection (8) 9 included in systematic review, √ 8-9
and, if applicable, included in
the meta-analysis).
 Check if
section/topic (page no)  Item  PRISMA checklist item  Page number
done
Methods

Describe method of data

extraction from reports (eg,
piloted forms, independently, in
Data collection process (9) 10 √ 11
duplicate) and any processes for
obtaining and confirming data
from investigators.
 Check if
section/topic (page no)  Item  PRISMA checklist item  Page number
done
Methods
List and define all variables for
which data were sought (eg,
Data items (9) 11 PICOS, funding sources) and any √ 11
assumptions and simplifications
made.
 Check if
section/topic (page no)  Item  PRISMA checklist item  Page number
done

Methods
Describe methods used for
assessing risk of bias of individual
studies (including specification of
Risk of bias in individual studies (10) 12 whether this was done at the study √ 12
or outcome level), and how this
information is to be used in any
data synthesis.
 Check if
section/topic (page no)  Item  PRISMA checklist item  Page number
done
Methods

State the principal summary

Summary measures (11) 13 measures (eg, risk ratio, difference √ 10
in means)
 Check if
section/topic (page no)  Item  PRISMA checklist item  Page number
done
Methods
Describe the methods of handling
data and combining results of
Synthesis of results (11) 14 studies, if done, including -  
measures of consistency (eg, I2)
for each meta-analysis.
 Check if
section/topic (page no)  Item  PRISMA checklist item  Page number
done
Methods

Specify any assessment of risk

of bias that may affect the
Risk of bias across studies (11) 15 cumulative evidence (eg, √ 10
publication bias, selective
reporting within studies).
 Check if
section/topic (page no)  Item  PRISMA checklist item  Page number
done
Methods

Describe methods of additional

analyses (eg, sensitivity or
Additional analyses (12) 16 subgroup analyses, meta- √ 11
regression), if done, indicating
which were prespecified.
 Check if
section/topic (page no)  Item  PRISMA checklist item  Page number
done
Results 
Give numbers of studies screened,
assessed for eligibility, and
Study selection (13) 17 included in the review, with √ 8
reasons for exclusions at each
stage, ideally with a flow diagram.
 Check if
section/topic (page no)  Item  PRISMA checklist item  Page number
done
Results 

For each study, present

characteristics for which data
Study characteristics (14) 18 were extracted (eg, study size, √ 11
PICOS, follow-up period) and
provide the citations.
 Check if
section/topic (page no)  Item  PRISMA checklist item  Page number
done
Results 

Present data on risk of bias of

each study and, if available, any
risk of bias within studies (15) 19 √ 12
outcome level assessment (see
item 12).
 Check
section/topic (page no)  Item  PRISMA checklist item  Page number
if done
Results 

For all outcomes considered (benefits or harms),

present, for each study: (a) simple summary
Results of individual studies (16) 20 data for each intervention group (b) effect √ 10-11
estimates and confidence intervals, ideally with
a forest plot.
 Check
section/topic (page no)  Item  PRISMA checklist item  Page number
if done
Results 

Present results of each meta-analysis done,

Synthesis of results (17) 21 including confidence intervals and measures of √ 12
consistency.
 Check
section/topic (page no)  Item  PRISMA checklist item  Page number
if done
Results 

Present results of any assessment of risk of bias

Risk of bias within studies (18) 22 across studies (see item 15)
√ 12
 Check
section/topic (page no)  Item  PRISMA checklist item if  Page number
done
Results 

Give results of additional analyses, if done

Additional analysis (18) 23 (eg, sensitivity or subgroup analyses, meta- √ 11
regression (see item 16)).
 Check if
section/topic (page no)  Item  PRISMA checklist item  Page number
done
Discussion

Summarise the main findings

including the strength of evidence
for each main outcome; consider
Summary of evidence (18) 24 their relevance to key groups (eg,
√ 12-13
healthcare providers, users, and
policy makers).
 Check if
section/topic (page no)  Item  PRISMA checklist item  Page number
done

Discussion

Discuss limitations at study and

outcome level (eg, risk of bias), and
Limitations (18) 25 at review level (eg, incomplete √ 13-14
retrieval of identified research,
reporting bias).
 Check if
section/topic (page no)  Item  PRISMA checklist item  Page number
done

Discussion

Provide a general interpretation of

the results in the context of other
Conclusions (19) 26 evidence, and implications for future
√ 14
research.
 Check if
section/topic (page no)  Item  PRISMA checklist item  Page number
done
Funding

Describe sources of funding

for the systematic review and
Funding (19) 27 other support (eg, supply of √ 14-15
data); role of funders for the
systematic review.
TERIMA
KASIH